|
|||||
|
|

Specialty insurance provider Skyward Specialty Insurance (NASDAQ:SKWD) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 27.1% year on year to $382.5 million. Its non-GAAP profit of $1.05 per share was 18.6% above analysts’ consensus estimates.
Is now the time to buy SKWD? Find out in our full research report (it’s free for active Edge members).
Skyward Specialty Insurance’s third quarter results stood out for robust top-line expansion and profitability, with revenue and non-GAAP earnings both surpassing Wall Street expectations. Management attributed this performance to outsized growth in the Agriculture unit—particularly in U.S. dairy and livestock—and continued strength in Accident & Health, Captives, Surety, and specialty programs. CEO Andrew Robinson emphasized, “Our results highlight the strength, durability and execution excellence of our Rule Our Niche strategy,” pointing to the company’s diversified portfolio as a shield against challenging property and casualty markets. Growth was balanced with underwriting discipline, especially in more competitive or inflation-exposed segments.
Looking forward, Skyward Specialty Insurance’s outlook is shaped by the integration of new specialty programs, disciplined underwriting in a more competitive property and casualty environment, and the anticipated closing of the Apollo acquisition in early 2026. Management expects future growth to be uneven due to the renewal cycles of key divisions, with Mark Haushill, CFO, noting, “There will be quarters where growth is lower than what we have reported in each of the first 3 quarters this year.” The company remains focused on expanding fee-based business lines and leveraging technology, such as AI-driven underwriting tools, to maintain its competitive edge and adapt to evolving market dynamics.
Management attributed the quarter’s results to exceptional Agriculture segment performance, targeted growth in non-cyclical units, and active risk management in the face of industry competition.
Management expects future performance to be shaped by the integration of new specialty programs, disciplined underwriting, and the closing of the Apollo acquisition, while remaining attentive to cyclical risks and operational efficiency.
Looking ahead, our analyst team will be closely watching (1) the successful integration and performance of new specialty programs and the Agriculture unit’s continued momentum, (2) progress toward the Apollo acquisition closing and its impact on capital structure and business mix, and (3) management’s ability to sustain underwriting discipline in increasingly competitive property and E&S markets. The ongoing deployment of AI-driven underwriting tools and efficiency initiatives will also be important markers for future profitability.
Skyward Specialty Insurance currently trades at $45.70, up from $44.98 just before the earnings. Is the company at an inflection point that warrants a buy or sell? The answer lies in our full research report (it’s free for active Edge members).
Trump’s April 2025 tariff bombshell triggered a massive market selloff, but stocks have since staged an impressive recovery, leaving those who panic sold on the sidelines.
Take advantage of the rebound by checking out our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
| Oct-31 | |
| Oct-30 | |
| Oct-30 | |
| Oct-30 | |
| Oct-29 | |
| Oct-29 | |
| Oct-29 | |
| Oct-29 | |
| Oct-29 | |
| Oct-29 | |
| Oct-28 | |
| Oct-28 | |
| Oct-27 | |
| Oct-22 | |
| Oct-13 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite